Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

E-Learning could sharpen Doctors' eye for skin cancer

NCT ID NCT07757386

Knowledge-focused Sponsor: Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial tests whether an online training course, called MelaMEd, can improve primary care doctors' ability to detect and manage melanoma, the most serious form of skin cancer. Participants—general practitioners, trainees, and pediatricians—answer questions and review skin lesion images before and after completing the course. Researchers compare the results to see if the training boosts knowledge, diagnostic accuracy, and appropriate referral decisions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
MelaMEd online training program
What this could lead to
If effective, this training could improve early melanoma detection and referral decisions in primary care, potentially saving lives.
What could go wrong
This is a single-group study without a comparison group, so improvements may not be solely due to the training. Results may not generalize beyond the participating doctors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,531 people

The number who actually took part.

Started

Jun 2022

Finished

Dec 2023

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Licensed general practitioners, general practitioners in training, or pediatricians working in the healthcare system areas served by participating Italian Melanoma Intergroup centers. * Voluntary agreement to participate in the study evaluation. * Confirmation that the participant had read and understood the information on personal data processing. * Authorization for the processing of personal data in accordance with European Union Regulation 2016/679. Exclusion Criteria: * No formal exclusion criteria were specified. * Individuals who did not authorize the processing of their personal data could access the MelaMEd educational course and platform but were not included in the evaluation of the training program.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cutaneous melanoma are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cutaneous melanoma melanoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cutaneous melanoma

Contacts and locations

Locations

  • Clinica Dermatologica, Fondazione IRCCS Policlinico San Matteo Pavia, Università degli Studi di Pavia, Pavia

    Pavia, Lombardy, 27100, Italy

  • Dermatology and Dermosurgery Unit, San Giuseppe Moscati Hospital

    Avellino, Campania, 83100, Italy

  • Dipartimento di Medicina, Chirurgia e Farmacia, Università di Sassari, Sassari

    Sassari, Sardinia, 07100, Italy

  • Divisione di Dermatologia Cesena/Forlì AUSL Romagna e Dipartimento di Medicina e Chirurgia, Università di Bologna

    Cesena, Emilia-Romagna, 47521, Italy

  • Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Roma

    Rome, Lazio, 00167, Italy

  • Melanoma Skin Centre, ASST dei Sette Laghi, Ospedale di Circolo e Fondazione Macchi

    Varese, Lombardy, 21100, Italy

  • SC Dermatologia, Dipartimento di Medicina e Chirurgia, Università di Parma, Parma

    Parma, Emilia-Romagna, 43126, Italy

  • Section of Dermatology and Infectious Diseases, University of Ferrara

    Ferrara, Emilia-Romagna, 44121, Italy

  • Unità di Dermatologia, ASST Papa Giovanni XXIII Ospedale di Bergamo, Bergamo

    Bergamo, Lombardy, 24127, Italy

  • Unità di Dermatologia, Azienda Socio Sanitaria Territoriale (ASST) Lecco, Ospedale Alessandro Manzoni, Lecco

    Lecco, Lombardy, 23900, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.